Immune and Physical Recovery Following Cesarean Delivery
NCT ID: NCT04358757
Last Updated: 2024-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2019-11-22
2023-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammation in Obese Parturients: Surgical Outcomes After Elective Caesarean Section
NCT01836315
Persistent Pain After CS Delivery
NCT01996592
Longitudinal Study Evaluating Recovery After Scheduled Cesarean Delivery
NCT04462107
Anesthetic Considerations for Repeat Cesarean Section - a Prospective Study
NCT04693572
Mothers' Experience of Category 1 Cesarean Section
NCT05840367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim- to determine whether perioperative immune function can predict women who are likely to have delayed physical recovery or recover poorly as demonstrated by lower scores on subjective clinical questionnaires and collected via watch actigraphy. This will help to determine whether a pre-existing deficient immune state is responsible for a worse recovery profile, which could be identified preoperatively. Similarly whether an impairment in response to surgery is demonstrable, which predisposes women to worse recovery profiles will be evaluated.
Ultimately, earlier identification of at-risk parturients (for example, through a preoperative bedside test) may lead to earlier interventions / patient centred care, in an attempt to improve their recovery trajectory and patient experience.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cesarean patients
participants undergoing elective cesarean will have measures of recovery assessed (patient-reported outcome measures and activity data from watch)
Elective cesarean delivery
scheduled cesarean delivery for maternal / obstetric indications
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elective cesarean delivery
scheduled cesarean delivery for maternal / obstetric indications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>20 to \<50 years old,
* single pregnancy term
* gestational age 37-41 weeks pregnancy,
* elective cesarean delivery,
* spinal or combined spinal-epidural anesthesia as primary anesthesia mode,
* multimodal analgesia regimen (including intrathecal morphine and regular acetaminophen and NSAIDs), single center at Stanford.
* ASA grade 1 or 2.
* gestational diabetes (not requiring insulin or diabetes medications and pre-eclampsia (without severe features) will be included.
* ethnic background: all ethnic backgrounds will be included gender: pregnant women only
Exclusion Criteria
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PSultan
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pervez Sultan, MBChB, FRCA, MD(Res)
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
51414
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.